You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is there a limit to vascepa refills?



The provided sources do not give any information regarding the limit to Vascepa refills. However, the sources do provide some useful information about Vascepa.

Vascepa is a prescription medication that contains icosapent ethyl, which is used to reduce triglyceride levels in adults with severe hypertriglyceridemia [3]. Vascepa is a brand-name drug that is manufactured by Amarin Pharma Inc. [1].

According to the New York State Medicaid Pharmacy & Therapeutics Committee, Vascepa is covered under the New York State Medicaid fee-for-service program [2]. However, coverage may be subject to certain limitations and restrictions, which are outlined in the New York State Medicaid Pharmacy & Therapeutics Committee's Preferred Drug List (PDL) [2].

Medscape notes that the recommended dose of Vascepa is 4 grams daily, taken as either two 1-gram capsules twice daily or four 0.5-gram capsules twice daily, with meals [3]. The medication is available in 0.5-gram and 1-gram capsules [3].

In conclusion, the provided sources do not give any information regarding the limit to Vascepa refills. However, they do provide useful information about the medication, including its manufacturer, indications, recommended dosage, and availability. Patients who have questions about Vascepa refills should consult their healthcare provider or pharmacist for more information.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf
[3] https://reference.medscape.com/drug/vascepa-icosapent-999764



Follow-up:   How often can Vascepa be refilled? Is there a maximum number of Vascepa refills? Are there any restrictions on Vascepa refill quantities?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.